Running a phase 3 trial for a new drug for gonorrhoea during the coronavirus pandemic Access Viewpoint here: Running a phase 3 trial for a new drug for gonorrhoea during the coronavirus pandemic – by Markus Heep, Esther Bettiol, Tanyaporn Wansom and Hilary Johnstone Authors: Markus Heep, Esther Bettiol, Tanyaporn Wansom & Hilary Johnstone Tags: Antimicrobial Viewpoint article, Phase 3, Regulatory, Gonorrhoea, STI, Gram negative, WHO priority pathogens
